Singapore launches S$4.8 M study award to support students in pursuing meaningful careers in biopharma industry

Singapore’s biopharmaceutical industry has launched a S$4.8 million study award to strengthen its manufacturing talent pipeline. The initiative, the first of its kind in Singapore for the industry, will support polytechnic and Institute of Technical Education (ITE) students studying biomedical sciences-related courses as they pursue long- term careers in biopharmaceutical manufacturing.

Launched by the Biopharmaceutical Manufacturers’ Advisory Council (BMAC), an industry alliance comprising leading biopharmaceutical MNCs with manufacturing presence in Singapore, the BMAC Study Award offers students financial support and early industry exposure to drive interest and build industry-ready expertise. Each award recipient will receive:

1. A one-time cash award of S$3,000 – S$5,000;
2. Priority placement for internship opportunities with participating BMAC companies in their final year of study; and 
3. Opportunities to participate in exclusive BMAC-organised activities, such as fireside chats and site tours, to gain greater exposure to the industry and network with industry mentors.

Around 1,000 students from ITE, Nanyang Polytechnic, Ngee Ann Polytechnic, Republic Polytechnic, Singapore Polytechnic and Temasek Polytechnic are expected to benefit from the award over the next five years.

Applications for the BMAC Study Award will open in 2027 to Year 2 students enrolled in eligible Diploma/Higher Nitec biomedical-related courses at the polytechnics and ITE.